No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
No Data
No Data
No Data
Buy Rating Affirmed for PAVmed on Growth and Valuation Prospects Amidst Product Commercialization
TipRanksApr 15 05:16 ET
Express News | PAVmed Inc : Ascendiant Capital Markets Cuts Target Price to $26 From $30
Moomoo 24/7Apr 14 23:04 ET
Why PAVmed Inc. (PAVM) Dipped More Than Broader Market Today
Yahoo FinanceApr 10 18:15 ET
Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Yahoo FinanceApr 8 08:30 ET
Buy Rating Affirmed for PAVmed With Strategic Focus on Lucid Diagnostics and Veris Cancer Care Amid Adjusted Price Target
TipRanksMar 29 07:46 ET
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 28 09:47 ET
No Data
No Data